The biological industry refers to the industry that uses research results and methods of microbiology, biology, tissue engineering, biochemistry, etc. to manufacture and produce biological agents. Biopharmaceuticals mainly include genetically engineered drugs, blood products, vaccines, diagnostic reagents, and tissue engineering that can be used for disease prevention, treatment, and diagnosis.
Since biopharmaceuticals are designed based on relevant principles of biology and molecular biology, they can solve deep-seated problems that traditional medicine cannot solve, and play an irreplaceable role in the treatment of major diseases and the prevention of major epidemics.
The number of construction projects and newly started projects and the number of completed and put into production in my country's biopharmaceutical industry has been increasing year by year. It is conservatively estimated that the number of completed and put into production in the industry in 2020 has increased to 1,125. In recent years, the investment and financing amount of my country's biopharmaceutical industry has generally fluctuated and upward trend, with the industry's investment and financing amount in 2020 being 59.07 billion yuan.
The number of construction projects and newly started projects in my country's biopharmaceutical industry has been growing year by year, with an average annual compound growth rate exceeding 10%
The number of construction projects and newly started projects in China's biopharmaceutical industry has been growing year by year, with an average annual compound growth rate exceeding 10%. With the continuous development of my country's biopharmaceutical industry, it is conservatively estimated that the number of construction projects and newly started projects in my country's biopharmaceutical industry has maintained a relatively stable growth. In 2020, the number of construction projects and newly started projects in my country's biopharmaceutical industry was 1,862 and 1,273 respectively.
The number of all completed and put into production projects in my country's biopharmaceutical industry has been increasing year by year. It is conservatively estimated that the number of completed and put into production projects in the industry in 2020 increased to 1,125
2011-2017, the number of all completed and put into production projects in China's biopharmaceutical industry has been increasing year by year. In 2017, the number of completed and put into production projects in the industry was 845, with an average annual compound growth rate of up to 14%. The R&D environment of my country's biopharmaceutical industry is good from 2018 to 2019. With the continuous completion of new projects and construction projects in the industry, the number of projects put into production in the industry will continue to grow. It is conservatively estimated that the number of projects put into production in my country's biopharmaceutical industry in 2020 increased to 1,125.
The total investment and financing amount of my country's biopharmaceutical industry showed a fluctuation and upward trend. The industry's investment and financing amount in 2020 was 59.07 billion
According to IT Orange data, the overall investment and financing amount of my country's biopharmaceutical industry showed a fluctuation and upward trend from 2011 to 2020. In 2020, the investment and financing amount of my country's biopharmaceutical industry was 59.07 billion yuan, a year-on-year increase of 117%; the number of investment and financing events was 178, a year-on-year increase of 31%. As of February 24, 2021, the investment and financing amount of my country's biopharmaceutical industry was 11.78 billion yuan, and the number of investment and financing events was 50.
As of 2021, the incomplete summary of investment and financing events in China's biopharmaceutical industry is shown in the table below:
Key development directions and key development products of the biopharmaceutical industry investment mainly include genetic engineering drugs, development of active protein and peptide drugs, extraction, fermentation and production of Chinese herbal medicines and their effective biological active ingredients, development of various vaccines, monoclonal antibodies and enzyme diagnostic and therapeutic reagents, development of targeted drugs, etc. For details, please refer to the table below:
For more data, please refer to the " China Biopharmaceutical Industry Market Forecast and Investment Strategy Planning Analysis Report ". At the same time, the Forecast Industry Research Institute provides solutions such as industrial big data, industrial planning, industry application, industrial park planning, industrial investment promotion, IPO investment and feasibility research.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-